The EVERY Company Secures $55M Series D to Scale Precision Fermentation

Why It Matters

The raise underscores rising investor confidence in precision‑fermentation alternatives to animal‑derived proteins and could accelerate the transition away from conventional eggs, reshaping supply chains in the broader food industry.

Deal Summary

San Francisco‑based The EVERY Company announced the close of a $55 million Series D round led by McWin Capital Partners with participation from several strategic investors. The funding will be used to expand manufacturing capacity, move toward profitability, and grow its presence in the $270 billion egg market, especially in high‑volume bakery applications.